SELLAS Life Sciences amends severance agreements for two officers to 15 months base salary upon change of control

SELLAS Life Sciences Group, Inc.

Board approved amendments to change-in-control severance agreements for SVP/Chief Development Officer Dragan Cicic and SVP/CFO John Burns.
Amendments provide for severance of 15 months of then-current base salary upon termination in connection with a change of control.
Original agreements were dated December 14, 2021; other provisions remain unchanged.
Full text of amendments to be filed in next periodic report.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.